| 000 | 01612 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514213249.0 | ||
| 264 | 0 | _c20050303 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a0924-8579 | ||
| 024 | 7 |
_a10.1016/j.ijantimicag.2004.09.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKafetzis, D A | |
| 245 | 0 | 0 |
_aTreatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds? _h[electronic resource] |
| 260 |
_bInternational journal of antimicrobial agents _cJan 2005 |
||
| 300 |
_a26-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAmphotericin B _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntimony |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGreece |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aLeishmania infantum _xdrug effects |
| 650 | 0 | 4 |
_aLeishmaniasis, Visceral _xdrug therapy |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeglumine _xtherapeutic use |
| 650 | 0 | 4 | _aMeglumine Antimoniate |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aVelissariou, I M | |
| 700 | 1 | _aStabouli, S | |
| 700 | 1 | _aMavrikou, M | |
| 700 | 1 | _aDelis, D | |
| 700 | 1 | _aLiapi, G | |
| 773 | 0 |
_tInternational journal of antimicrobial agents _gvol. 25 _gno. 1 _gp. 26-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijantimicag.2004.09.011 _zAvailable from publisher's website |
| 999 |
_c15301812 _d15301812 |
||